News

Read the latest news and views from Lymphoma Action.

Use the drop down filter to find the most relevant news for you.

CHOP remains standard treatment for T-cell lymphoma

New approaches are needed for the treatment of people with T-cell lymphoma after disappointing results in the CHEMO-T trial.

Rituximab can help children with NHL

Adding rituximab to chemotherapy improves outcomes for under-18s with advanced-stage B-cell non-Hodgkin lymphoma (NHL)

Image of lots of blood vials with different coloured caps

RATHL trial: Reducing serious side effects and improving outcomes

Recently published findings from the phase 3 RATHL trial (Response-adapted therapy for advanced Hodgkin lymphoma) show that most people can be spared some side effects.